Signed in as:
filler@godaddy.com
Donald Kirsch has over 25 years experience in leadership and management in the pharmaceutical industry. He currently runs a biopharma consulting practice in Boston and New York, and teaches Drug Discovery and Management at the Harvard University Extension School and at MassBio. Previously he served as the Chief Scientific Officer (CSO) at Cambria Pharmaceuticals where he oversaw the development of drugs for the treatment of neurodegenerative diseases.
Prior to joining Cambria, Dr. Kirsch was a research manger at Squibb, where he served as a research group leader working on the discovery of natural product therapeutic drugs for anti-infective and cardiovascular applications, and as Director at and Genetics Institute and Wyeth, where he lead a genomics research group identifying new drug targets from genomic sequences. Dr. Kirsch received his bachelor’s degree in biochemistry from Rutgers College and his Ph.D. from Princeton University in molecular biology. Following a postdoctoral research appointment in the pharmacology department at Robert Wood Johnson Medical School, he joined the faculty there as an instructor prior to beginning his industrial career. Dr. Kirsch is the author of over 50 scientific publications and technical monographs, an inventor on 24 US patents and patent applications, and has served for over 20 years at the NIH as a reviewer of grant applications.

Eric Bloom is the Executive Director of the IT Management and Leadership Institute, a contributing writer to CIO.com, TEDx speaker, technologist, #1 bestselling author, PM/BA Times columnist, and a research advisor for IDC. Prior to his current role, Eric was a senior IT executive at various prestigious firms such as Fidelity Investments, Monster.com and Independence Investments. He is also a recognized thought leader on how to maximize the value of technical skill and knowledge though enhanced interpersonal communication and business acumen.
His past and present experience, combined with his deep understanding of major IT trends, like Digital Transformation, Cloud Computing, and Agile/Scrum makes him uniquely qualified to help C-Suite Executives, Project Managers, Scrum Masters and others prepare themselves and their organizations for success in an ever-changing business and technological landscape.
Eric has also been a nationally syndicated columnist, ITWorld.com contributing writer, and is the author of various books, including the following:
Eric has undergraduate degrees in Computer Systems and Accounting from Bentley University and an MBA from Babson College and is a past president of National Speakers Association New England. He was awarded a Certified Speaking Professional (CSP) designation by the National Speakers Association.

Maura Snow is a VP and Senior Consultant in Human Resources at Great Brook Biotech. She has over 20 years experience in the role of Senior Human Resources Leader with Fortune 100 companies, mid-sized organizations, and two-person start up environments. Prior to her current position, she served as VP, Human Resources at Basilea Pharmaceuticals, as HR Director at EMD Lexigen Research Center, and as HR Manager at Merck Medco
She holds a Masters degree in Public Administration from Brigham Young University, and is accredited by the Society for Human Resources Management. She currently serves on the Board of Directors of The Bioscience Network (TBN), a professional organization for scientists and operational professionals in life sciences. She is a member of the New England Compensation Consortium, The Boston Club, and a trusted affiliate of the Boston Business group. She is certified to deliver programs and profiles using Insights Discovery®.

Robert Gottlieb has more than 30 years of experience in the biotechnology and pharmaceutical industries as a consultant on strategy and communications, successfully working with over 100 companies and organizations ranging from start-ups in and outside of the U.S. to multi-nationals. Mr. Gottlieb brings particular expertise in corporate positioning, external and internal communications strategy, and preparation for financing and partnering.
He is currently a Principal at the communications and strategy consulting firm, RMG Associates. Prior to this, he co-founded Feinstein Kean Healthcare (now a division of Ogilvy Public Relations Worldwide), and directed press relations and corporate communications at Biogen Inc. In addition, he served as executive editor of F-D-C Reports, “The Pink Sheet,” where he covered the FDA and drug regulation, pharmaceutical business and the emergence of biotechnology as an industry, as well as founding The NDA Pipeline, a reference publication for the pharmaceutical and biotechnology industries, which has been published annually for more than 25 years.

Amy Russell, M.A. is an expert in intercultural communication, specializing Chinese language and culture. She coaches international professionals on communicating successfully in English and navigating American business culture. After studying Chinese at Columbia University, Ms. Russell earned Master's degrees in Chinese and in Translation and Interpretation of Chinese. Translating and teaching in Taiwan for two years enhanced her knowledge of Chinese social, business, and industrial culture. As a translator and interpreter in the US, Ms. Russell’s clients included the US Department of State, Sandia National Laboratories, Varian (a manufacturer of linear accelerators for oncology treatment), and many other technology firms. Ms. Russell recently completed certification in Teaching English as a Second Language. She is dedicated to helping her clients upskill their communication and intercultural competence.

Eliane Markoff has over 30 years in the high tech and biotech industries, specializing in business mediation, conflict resolution, strategic planning and team dynamics, and is currently the Ombuds at Bentley University. Previously she was an Adjunct Professor at Bentley University where she taught Team Management, Business Planning and Organizational Behavior. She was responsible for the development of programs and tools that leveraged intellectual capital across a Fortune 500 company, and served as a Principal Software Engineer designing expert systems.
She is the founder of Art in Giving, a non-profit company that promotes the fine arts of several artists and galleries to benefit childhood cancer research and other health causes. She is a member of the Board of Trustees for Wheelock College, The Boston Club, and the Leadership Council for The Kenneth Schwartz Center at Mass General Hospital. She earned her MBA from Boston College and is fluent in French and Arabic.

Copyright ©2026 Vivo Group - info1@VivoGroup.com 617-852-6635
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.